摘要
目的 分析经颅彩色多普勒超声(TCCS)联合ABCD3-I评估短暂性脑缺血发作(TIA)后脑梗死价值。方法 选取117例TIA患者采用TCCS检查和ABCD3-I量表进行评估,以数字剪影血管造影(DSA)或CT血管成像(CTA)为金标准评估颅内动脉狭窄程度以预警脑梗死风险。比较TCCS、ABCD3-I评估风险结果与金标准的符合情况,计算二者联合评估颅内血管狭窄程度的符合率。记录TCCS和ABCD3-I各自评估的风险亚组7 d脑梗死发生率,分析评价TCCS联合ABCD3-I预测TIA后7 d脑梗死效能。结果 TCCS联合ABCD3-I对颅内血管狭窄“无和轻度狭窄”“中度狭窄”“重度狭窄和闭塞”诊断或评估符合率分别为96.43%、89.47%、100%,TCCS联合ABCD3-I诊断或评估总符合率为95.73%(112/117),高于单用ABCD3-I评估符合率(P<0.01)。TCCS联合ABCD3-I诊断脑梗死的曲线下面积为0.946,95%CI为0.876~0.981,均大于TCCS和ABCD3-I单独诊断(P<0.01)。结论 TCCS联合ABCD3-I评估,能有效预测TIA脑梗死发生,有一定的临床价值,值得推广应用。
Objective To analyze the value of transcranial color-coded sonography(TCCS) plus ABCD3-I(Age,Blood Pressure,Clinical Features,Duration,and Diabetes plus Dual TIA) in evaluating cerebral infarction(CI) induced by transient ischemic attack(TIA).Methods Assessments were conducted in 117 TIA patients using the TCCS and ABCD(3)-I and the degrees of intracranial artery stenosis assessed using digital subtraction angiography(DSA) or CT angiography(CTA) as the gold standards to warn the risk of cerebral infarction.The risk results of TCCS and ABCD3-I assessment were compared with the gold standard and the coincidence rate of their joint assessment of stenosis was calculated.The incidences of 7 day cerebral infarction in risk subgroups assessed by TCCS and ABCD3-I were recorded and the efficacy of TCCS combined with ABCD3-I predicting 7day cerebral infarction after TIA analyzed and evaluated.Results The coincidence rates of TCCS plus ABCD3-I diagnosing or assessing 'null or mild stenosis','moderate stenosis',and 'severe stenosis or occlusion' of intracranial vascular stenosis were96.43%,89.47% and 100%,89.74%,respectively,the total coincidence rate of TCCS plus ABCD3-I was 95.73% and higher than that of separate ABCD3-I.The area under the ROC curve of TCCS plus ABCD3-I diagnosing cerebral infarction was 0.946 and 95% CI 0.876~0.981,both were higher than those of separate TCCS or ABCD3-I(P<0.01).Conclusion TCCS combined with ABCD3-I can effectively predict the occurrence of TIA cerebral infarction,has certain clinical value,and it is worthy of promotion and application.
作者
尚晓斌
李冉
王子凡
彭璐
张海三
Shang Xiaobin;Li Ran;Wang Zifan;Peng Lu;Zhang Haisan(The Second Affiliated Hospital of Xinxiang Medical University,Xinxiang 453002,Henan,China;不详)
出处
《临床心身疾病杂志》
CAS
2024年第2期40-45,共6页
Journal of Clinical Psychosomatic Diseases
基金
河南省医学科技攻关计划项目(编号LHGJ20210527)。
